Chihiro Kondoh

964 total citations
49 papers, 546 citations indexed

About

Chihiro Kondoh is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chihiro Kondoh has authored 49 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Chihiro Kondoh's work include Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Chihiro Kondoh is often cited by papers focused on Gastric Cancer Management and Outcomes (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Chihiro Kondoh collaborates with scholars based in Japan, United States and United Kingdom. Chihiro Kondoh's co-authors include Kei Muro, Takashi Ura, Kohei Shitara, Daisuke Takahari, Motoo Nomura, Takeshi Kodaira, Azusa Komori, Toshimi Takano, Shigenori Kadowaki and Naoto Sassa and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Chihiro Kondoh

43 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chihiro Kondoh Japan 13 302 241 160 109 72 49 546
Emi Noguchi Japan 12 352 1.2× 208 0.9× 51 0.3× 115 1.1× 120 1.7× 63 608
Juliette Haudebourg France 14 206 0.7× 268 1.1× 208 1.3× 144 1.3× 119 1.7× 37 651
Shota Shimizu Japan 13 361 1.2× 183 0.8× 162 1.0× 108 1.0× 91 1.3× 47 663
Edina Paál United States 13 420 1.4× 169 0.7× 366 2.3× 101 0.9× 41 0.6× 29 1.0k
Madoka Hamada Japan 17 401 1.3× 239 1.0× 370 2.3× 86 0.8× 35 0.5× 64 681
Č Neoral Czechia 11 200 0.7× 304 1.3× 363 2.3× 80 0.7× 61 0.8× 118 590
Christian Cotsoglou Italy 15 414 1.4× 241 1.0× 479 3.0× 162 1.5× 77 1.1× 46 904
Celso Abdon Lopes de Mello Brazil 16 379 1.3× 305 1.3× 191 1.2× 108 1.0× 160 2.2× 74 722
Yingbo Chen China 15 304 1.0× 422 1.8× 269 1.7× 86 0.8× 91 1.3× 36 723
Ioannis T. Konstantinidis United States 15 579 1.9× 435 1.8× 673 4.2× 88 0.8× 84 1.2× 28 915

Countries citing papers authored by Chihiro Kondoh

Since Specialization
Citations

This map shows the geographic impact of Chihiro Kondoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chihiro Kondoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chihiro Kondoh more than expected).

Fields of papers citing papers by Chihiro Kondoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chihiro Kondoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chihiro Kondoh. The network helps show where Chihiro Kondoh may publish in the future.

Co-authorship network of co-authors of Chihiro Kondoh

This figure shows the co-authorship network connecting the top 25 collaborators of Chihiro Kondoh. A scholar is included among the top collaborators of Chihiro Kondoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chihiro Kondoh. Chihiro Kondoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamanaka, T., Chihiro Kondoh, Maiko Noguchi, et al.. (2025). Artificial intelligence system for predicting hand-foot skin reaction induced by vascular endothelial growth factor receptor inhibitors. Scientific Reports. 15(1). 9843–9843. 1 indexed citations
3.
Kondoh, Chihiro, Woo Kyun Bae, Satoshi Tamada, et al.. (2025). First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia. Japanese Journal of Clinical Oncology. 55(4). 406–413. 2 indexed citations
4.
Hirota, Akira, Nobuyuki Takahashi, Hiromichi Nakajima, et al.. (2023). The impact of the COVID‐19 pandemic on perioperative chemotherapy for breast cancer. Cancer Medicine. 12(11). 12095–12105. 3 indexed citations
5.
Naito, Yoichi, Hiromichi Nakajima, Chihiro Kondoh, et al.. (2022). Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study. Japanese Journal of Clinical Oncology. 53(2). 105–114. 2 indexed citations
6.
Nakajima, Hiromichi, Kenichi Harano, Tokiko Nakai, et al.. (2022). Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer. The Breast. 61. 136–144. 11 indexed citations
7.
Yasui, Hisateru, Atsushi Takeno, Hiroki Hara, et al.. (2022). Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study. International Journal of Colorectal Disease. 37(6). 1393–1402. 8 indexed citations
8.
Mukohara, Toru, Ako Hosono, Sachiyo Mimaki, et al.. (2021). Effects of Ado-Trastuzumab Emtansine and Fam-Trastuzumab Deruxtecan on Metastatic Breast Cancer Harboring HER2 Amplification and the L755S Mutation. The Oncologist. 26(8). 635–639. 12 indexed citations
9.
Rini, Brian I., Michael B. Atkins, Elizabeth R. Plimack, et al.. (2021). Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial. European Urology Oncology. 5(2). 225–234. 25 indexed citations
10.
Naito, Yoichi, Chihiro Kondoh, Kenichi Harano, et al.. (2021). The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis. The Breast. 58. 50–56. 6 indexed citations
11.
12.
Kondoh, Chihiro, Woo Kyun Bae, Satoshi Tamada, et al.. (2020). 200O Pembrolizumab plus axitinib (pembro + axi) vs sunitinib in metastatic renal cell carcinoma (mRCC) outcomes of the KEYNOTE-426 study in patients from eastern Asia. Annals of Oncology. 31. S1319–S1319. 3 indexed citations
13.
Tomita, Yoshihiko, Katsunori Tatsugami, Noboru Nakaigawa, et al.. (2020). Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients. International Journal of Urology. 27(11). 952–959. 22 indexed citations
14.
15.
Mitani, Seiichiro, Shigenori Kadowaki, Azusa Komori, et al.. (2020). A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies. Advances in Therapy. 37(6). 2853–2864. 5 indexed citations
16.
Takahashi, Momoko, Yukinori Ozaki, Jun Masuda, et al.. (2019). Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review. BMC Cancer. 19(1). 980–980. 45 indexed citations
17.
Suzuki, Takeshi, Yasutaka Sukawa, Chiyo K. Imamura, et al.. (2019). A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure–Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial). Clinical Colorectal Cancer. 19(1). 13–21.e3. 19 indexed citations
18.
Inoshita, Naoko, Yuji Miura, Ryosuke Oki, et al.. (2018). The loss of BAP1 protein expression predicts poor prognosis in patients with nonmetastatic clear cell renal cell carcinoma with inferior vena cava tumor thrombosis. Urologic Oncology Seminars and Original Investigations. 36(8). 365.e9–365.e14. 7 indexed citations
19.
Oki, Ryosuke, Chihiro Kondoh, Yuji Miura, et al.. (2017). S-1 plus cisplatin combination therapy in patients with urachal carcinoma: A retrospective study. Annals of Oncology. 28. x84–x84.
20.
Gyawali, Bishal, Tomoya Shimokata, Kazunori Honda, et al.. (2016). Loss of muscle mass associated with the long term use of mTOR inhibitors. Annals of Oncology. 27. vii87–vii87. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emi Noguchi Breakdown of academic impact, for papers by Juliette Haudebourg Breakdown of academic impact, for papers by Shota Shimizu Breakdown of academic impact, for papers by Edina Paál Breakdown of academic impact, for papers by Madoka Hamada Breakdown of academic impact, for papers by Č Neoral Breakdown of academic impact, for papers by Christian Cotsoglou Breakdown of academic impact, for papers by Celso Abdon Lopes de Mello Breakdown of academic impact, for papers by Yingbo Chen Breakdown of academic impact, for papers by Ioannis T. Konstantinidis
Rankless by CCL
2026